Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Knoll licenses technology for use in cardiovascular research

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Inactivation of SIV by LifeTECH's blood sterilization technology

Dec. 17, 1996

Celox Laboratories' ViaStem receives patent coverage

Dec. 16, 1996

Epic receives patent coverage for core drug delivery technology

Dec. 16, 1996

Terrapin Technologies obtains rights to Walter Reed compound library

Dec. 16, 1996

Visible Genetics acquires BIOS Laboratories technology

Dec. 13, 1996

Myriad Genetics announces research collaboration

Dec. 13, 1996

CEPRATE SC approved for marketing in U.S.

Dec. 12, 1996

Drugs quicker to reach market in U.S. than in Germany and Japan

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...